Disseminated Mycobacterium tuberculosis infection due to interferon γ deficiency. Response to replacement therapy

Seneviratne, Suranjith Luke; Doffinger, Rainer; Macfarlane, John; Ceron-Gutierrez, I.; Kashipaz, M. R. Amel; Robbins, A.; Patel, I.; Powell, P. T.; Kumararatne, D. S.; Powell, Richard J.
January 2007
Thorax;Jan2007, Vol. 62 Issue 1, p97
Academic Journal
The case of a previously healthy HIV seronegative woman with disseminated Mycobacterium tuberculosis infection and markedly reduced interferon γ production is reported here. Complete healing of her disseminated lesions was seen only after addition of subcutaneous interferon y to her tuberculosis treatment.


Related Articles

  • How to use: interferon γ release assays for tuberculosis. Pollock, Louisa; Roy, Robindra Basu; Kampmann, Beate // Archives of Disease in Childhood -- Education & Practice Edition;Jun2013, Vol. 98 Issue 3, p99 

    Diagnosis and treatment of latent tuberculosis infection (LTBI) is important to reduce risk of progression to active tuberculosis (TB) disease. For the past century the tuberculin skin test (TST) has been used as a measure of exposure to Mycobacterium tuberculosis (MTB), but this test has...

  • Levels of Interferon-Gamma Increase after Treatment for Latent Tuberculosis Infection in a High-Transmission Setting. Takenami, Iukary; Finkmoore, Brook; Machado Jr., Almério; Emodi, Krisztina; Riley, Lee W.; Arruda, Sérgio // Pulmonary Medicine;2012, p1 

    Objectives. We investigated IFN-y levels before and after a six month course of isoniazid among individuals with latent tuberculosis infection (LTBI) in a high-transmission setting. Design. A total of 26 household contacts of pulmonary tuberculosis patients who were positive for LTBI by...

  • Comparison of Interferon-γ Release Assay to Two Cut-Off Points of Tuberculin Skin Test to Detect Latent Mycobacterium tuberculosis Infection in Primary Health Care Workers. de Souza, Fernanda Mattos; do Prado, Thiago Nascimento; Pinheiro, Jair dos Santos; Peres, Renata Lyrio; Lacerda, Thamy Carvalho; Loureiro, Rafaela Borge; Carvalho, Jose Américo; Fregona, Geisa; Dias, Elias Santos; Cosme, Lorrayne Beliqui; Rodrigues, Rodrigo Ribeiro; Riley, Lee Wood; Maciel, Ethel Leonor Noia // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Background: An interferon-γ release assay, QuantiFERON-TB (QFT) test, has been introduced an alternative test for the diagnosis of latent Mycobacterium tuberculosis infection (LTBI). Here, we compared the performance of QFT with tuberculin skin test (TST) measured at two different cut-off...

  • CLINICAL UTILITY OF THE TUBERCULOSIS INTERFERON GAMMA TEST (IGT) IN A LOW INCIDENCE AREA. Donovan, J. T.; Yogendran, A.; Ramsay, I. D.; Giles, C.; Lee, R. W.; Scourfield, A. T.; Doffman, S. R. // Thorax;Dec2011 Supplement, pA74 

    Introduction The clinical utility and cost effectiveness of IGT in low prevalence areas of TB remains unclear. In some clinical settings it has been used to exclude active disease. We describe the experience of IGT in a teaching hospital in a low prevalence area (13/100 000). Methods We...

  • Role of QuantiFERON-TB Gold, Interferon Gamma Inducible Protein-10 and Tuberculin Skin Test in Active Tuberculosis Diagnosis. Kabeer, Basirudeen Syed Ahamed; Raman, Balambal; Thomas, Aleyamma; Perumal, Venkatesan; Raja, Alamelu // PLoS ONE;2010, Vol. 5 Issue 2, p1 

    Background: The measurement of Interferon gamma or Interferon gamma inducible protein (IP)-10 in antigen stimulated blood samples is suggested as an alternative method for latent tuberculosis (TB) diagnosis. Nonetheless, their role in active TB diagnosis, particularly in TB endemic settings is...

  • Comparison of an In-house and a Commercial RD1-based ELISPOT-IFN-γ Assay for the Diagnosis of Mycobacterium tuberculosis Infection. Mantegani, Paola; Piana, Federica; Codecasa, Luigi; Galli, Laura; Scarpellini, Paolo; Lazzarin, Adriano; Cirillo, Daniela; Fortis, Claudio // Clinical Medicine & Research;Dec2006, Vol. 4 Issue 4, p266 

    Objective: To compare a RD1-based in-house ELISPOT-interferon-γ (IFN-γ) assay with a commercial (T-SPOT.TB™) assay for the diagnosis of Mycobacterium tuberculosis (TB) infection and the efficacy of the tuberculin skin test (TST) and ELISPOT assay in detecting latent TB infection...

  • The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda. Biraro, Irene Andia; Kimuda, Simon; Egesa, Moses; Cose, Stephen; Webb, Emily L.; Joloba, Moses; Smith, Steven G.; Elliott, Alison M.; Dockrell, Hazel M.; Katamba, Achilles // PLoS ONE;1/15/2016, Vol. 11 Issue 1, p1 

    Background: In the absence of a gold standard for the diagnosis of latent tuberculosis (TB) infection (LTBI), the current tests available for the diagnosis of LTBI are limited by their inability to differentiate between LTBI and active TB disease. We investigated IP-10 as a potential biomarker...

  • Caspofungin/rifampicin interaction.  // Reactions Weekly;10/6/2012, Issue 1422, p15 

    The article describes the case of a 65-year-old woman who developed Candida (C.) parapsilosis candidaemia due to failure of treatment with caspofungin for C. lusitaniae while receiving rifampicin for Mycobacterium tuberculosis.

  • Latent Mycobacterium tuberculosis?persistence, patience, and winning by waiting. Manabe, Yukari C.; Bishai, William R. // Nature Medicine;Dec2000, Vol. 6 Issue 12, p1327 

    Mycobacterium tuberculosis is a globally successful pathogen due to its ability to persist for long periods of time unrecognized by the human immune system. The panoply of genes that allows the organism to enter latency and then re-emerge later during endogenous reinfection are now being...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics